• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Aegerion pleads guilty to US marketing violations pharmatimes
    September 26, 2017
    Aegerion Pharmaceuticals will pay $40.1 million to resolve US investigations into marketing and sales of its cholesterol drug Juxtapid, authorities said on Friday.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service